Altimmune, Inc.
NASDAQ
United States of America
Late-stage biopharmaceutical company developing therapies for liver diseases
Lead candidate pemvidutide targets metabolic and alcohol-associated liver disease
Gaithersburg, Maryland 20878, United States
Jerry Durso
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder

1 entries
DateDescription
2026-01-01
+ Loaded when opened
2026-09-21 18:15 (Model: )
↑